Published in Women's Health Weekly, April 22nd, 2004
These applications utilize Applied Imaging's Ariol system to assist in the analysis of tests that are important factors in the selection of certain breast cancer patients to receive hormonal therapies such as Tamoxifen. Along with the previously cleared Her-2/neu application, ER and PR comprise the most commonly used panel of immunohistochemistry tests for breast cancer assessment in the clinical pathology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly